17.12.2007 13:02:00

Chemtura Names Dr. Robert Wedinger Chief Business Officer

Chemtura Corporation(NYSE:CEM) has appointed Robert S. Wedinger, PhD as chief business officer, reporting directly to Chairman and Chief Executive Officer Robert Wood. Dr. Wedinger is now responsible for Chemtura's commercial organization and its four businesses: Polymer Additives, Performance Specialties, Crop and Consumer Products. Dr. Wedinger, who was serving as group president of Performance Specialties, will retain his Performance Specialties role in addition to his new responsibilities. He joined Chemtura in 2006 as vice president and general manager of Process Chemicals and Polymers. Dr. Wedinger came to Chemtura from J.M. Huber Corporation in Maryland, a private diversified manufacturer, where he served as vice president and general manager of the performance materials business and the consumer products business. His previous positions include vice president and general manager of pharmaceutical fine chemicals for Honeywell International (AlliedSignal) in New Jersey; and global technical director for the food ingredients division of FMC Corporation in Pennsylvania. Dr. Wedinger holds 10 U.S. patents and has three patents pending. He earned a Bachelor of Science in chemistry and biology from Wagner College and a Ph.D. in physical organic chemistry from the State University of New York at Stony Brook. He was a post-doctoral research fellow in synthetic organic chemistry at Harvard University. Dr. Wedinger is also a member of the SOCMA Board of Directors. About Chemtura Chemtura Corporation (NYSE:CEM), with pro forma 2006 sales of $3.5 billion, is a global manufacturer and marketer of specialty chemicals, crop protection and pool, spa and home care products. Please visit www.chemtura.com.
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu DuPont (E. I. DuPont de Nemours and Co.)mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu DuPont (E. I. DuPont de Nemours and Co.)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

S&P 600 SmallCap 935,46 -0,94%